A successful screening program relies on the ability of radiologists to detect potential malignancies while maintaining an acceptably low recall rate. To do so requires rigorous adherence to quality controls for both personnel and equipment, as warranted by the US…
Acknowledgments The authors thank Diana Frillici and Annette Wiebeld for their valuable input. Introduction The limitations of conventional digital mammography have been well established. Conventional mammography creates a two-dimensional (2D) image of a three-dimensional (3D) structure, which may result in…
The introduction of tomosynthesis to an imaging facility is a positive experience for mammography technologists. Tomosynthesis improves the clinical workflow not only by allowing faster patient throughput but also by improving diagnostic accuracy, benefiting both the patients and breast imaging…
Screening mammography has undergone many improvements since widespread screening began in the 1980s. These improvements have led to improved image quality, reduced radiation dose, and more accurate examinations. In the early 2000s there was a major shift in imaging technology,…
You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here
When a suspicious finding is seen on a breast magnetic resonance imaging (MRI) examination and other imaging and clinical examinations are negative, the only way to perform a biopsy of the lesion is by using MRI guidance. All facilities that…
More than 2 million women in the United States have undergone breast implantation since the 1960s, either for cosmetic augmentation or breast reconstruction. During this time, both the silicone controversy and the known complications of breast augmentation have necessitated an…
The breast undergoes significant anatomic and histologic changes after intervention. Posttreatment imaging findings have been thoroughly described for mammography and breast ultrasound, but only isolated descriptions of postsurgical breast changes seen on dynamic contrast enhanced (DCE) breast magnetic resonance imaging…
In the absence of distant metastatic disease, breast cancer staging is based on the extent of local-regional disease in the breast and axilla. The American Joint Committee on Cancer TNM system is used to provide breast cancer patients and their…
Some benign pathologic entities of the breast, when diagnosed at image-guided core needle biopsies, have the potential to be upgraded to invasive carcinoma or ductal carcinoma in situ (DCIS) upon complete excision by surgery. These entities are collectively categorized as…